Annual CFO
-$18.28 M
-$2.63 M-16.82%
December 31, 2023
Summary
- As of March 7, 2025, UNCY annual cash flow from operations is -$18.28 million, with the most recent change of -$2.63 million (-16.82%) on December 31, 2023.
- During the last 3 years, UNCY annual CFO has fallen by -$16.82 million (-1153.12%).
- UNCY annual CFO is now -1454.68% below its all-time high of -$1.18 million, reached on December 31, 2019.
Performance
UNCY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$9.25 M
-$2.93 M-46.42%
September 30, 2024
Summary
- As of March 7, 2025, UNCY quarterly cash flow from operations is -$9.25 million, with the most recent change of -$2.93 million (-46.42%) on September 30, 2024.
- Over the past year, UNCY quarterly CFO has dropped by -$4.81 million (-108.43%).
- UNCY quarterly CFO is now -12573.97% below its all-time high of -$73.00 thousand, reached on March 31, 2020.
Performance
UNCY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$26.47 M
-$4.83 M-22.32%
September 30, 2024
Summary
- As of March 7, 2025, UNCY TTM cash flow from operations is -$26.47 million, with the most recent change of -$4.83 million (-22.32%) on September 30, 2024.
- Over the past year, UNCY TTM CFO has dropped by -$8.18 million (-44.76%).
- UNCY TTM CFO is now -36154.79% below its all-time high of -$73.00 thousand, reached on March 31, 2020.
Performance
UNCY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
UNCY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.8% | -108.4% | -44.8% |
| 3 y3 years | -1153.1% | -108.4% | -44.8% |
| 5 y5 years | -1454.7% | -108.4% | -44.8% |
UNCY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -217.0% | at low | -559.4% | at low | -358.9% | at low |
| 5 y | 5-year | -1454.7% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -1454.7% | at low | <-9999.0% | at low | <-9999.0% | at low |
Unicycive Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.25 M(+46.4%) | -$26.47 M(+22.3%) |
| Jun 2024 | - | -$6.32 M(-2.1%) | -$21.64 M(+3.9%) |
| Mar 2024 | - | -$6.46 M(+45.4%) | -$20.82 M(+13.9%) |
| Dec 2023 | -$18.28 M(+16.8%) | -$4.44 M(+0.4%) | -$18.28 M(-8.3%) |
| Sep 2023 | - | -$4.42 M(-19.6%) | -$19.93 M(+4.5%) |
| Jun 2023 | - | -$5.50 M(+40.4%) | -$19.07 M(+14.8%) |
| Mar 2023 | - | -$3.92 M(-35.6%) | -$16.61 M(+6.2%) |
| Dec 2022 | -$15.65 M | -$6.08 M(+70.8%) | -$15.65 M(+42.7%) |
| Sep 2022 | - | -$3.56 M(+16.9%) | -$10.97 M(+0.8%) |
| Jun 2022 | - | -$3.05 M(+3.0%) | -$10.88 M(+35.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.96 M(+110.8%) | -$8.05 M(+39.6%) |
| Dec 2021 | -$5.77 M(+295.3%) | -$1.40 M(-59.6%) | -$5.77 M(+17.6%) |
| Sep 2021 | - | -$3.47 M(+1500.9%) | -$4.90 M(+129.7%) |
| Jun 2021 | - | -$217.00 K(-67.8%) | -$2.13 M(+3.6%) |
| Mar 2021 | - | -$673.00 K(+25.1%) | -$2.06 M(+41.1%) |
| Dec 2020 | -$1.46 M(+24.1%) | - | - |
| Dec 2020 | - | -$538.00 K(-23.8%) | -$1.46 M(+58.4%) |
| Sep 2020 | - | -$706.00 K(+397.2%) | -$921.00 K(+328.4%) |
| Jun 2020 | - | -$142.00 K(+94.5%) | -$215.00 K(+194.5%) |
| Mar 2020 | - | -$73.00 K | -$73.00 K |
| Dec 2019 | -$1.18 M | - | - |
FAQ
- What is Unicycive Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual CFO year-on-year change?
- What is Unicycive Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly CFO year-on-year change?
- What is Unicycive Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Unicycive Therapeutics?
- What is Unicycive Therapeutics TTM CFO year-on-year change?
What is Unicycive Therapeutics annual cash flow from operations?
The current annual CFO of UNCY is -$18.28 M
What is the all time high annual CFO for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual cash flow from operations is -$1.18 M
What is Unicycive Therapeutics annual CFO year-on-year change?
Over the past year, UNCY annual cash flow from operations has changed by -$2.63 M (-16.82%)
What is Unicycive Therapeutics quarterly cash flow from operations?
The current quarterly CFO of UNCY is -$9.25 M
What is the all time high quarterly CFO for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly cash flow from operations is -$73.00 K
What is Unicycive Therapeutics quarterly CFO year-on-year change?
Over the past year, UNCY quarterly cash flow from operations has changed by -$4.81 M (-108.43%)
What is Unicycive Therapeutics TTM cash flow from operations?
The current TTM CFO of UNCY is -$26.47 M
What is the all time high TTM CFO for Unicycive Therapeutics?
Unicycive Therapeutics all-time high TTM cash flow from operations is -$73.00 K
What is Unicycive Therapeutics TTM CFO year-on-year change?
Over the past year, UNCY TTM cash flow from operations has changed by -$8.18 M (-44.76%)